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SUMMARY There is an overlap between amyotrophic lateral sclerosis and frontotemporal dementia. Approximately 
15% of amyotrophic lateral sclerosis patients suffer from frontotemporal dementia characterized by behavioral change 
while a further third experience subtle executive dysfunction (typically letter fluency deficits) and corresponding prefrontal 
changes. Behavior change appears prevalent with apathy being the most prominent feature. Reports of social and emotional 
cognition deficits are increasing. Deficits have been described on theory of mind tasks including interpretation of stories and 
cartoons, faux pas detection and in the judgment of preference based on direction of eye-gaze. Impairments in emotional 
face and prosody perception and emotional enhancement of memory have been reported, and decision making (with and 
without risk) appears affected. The role of executive dysfunction in this social cognition deficit remains unresolved and more 
direct evidence of oribitofrontal involvement has yet to be found. Implications for healthcare provision are discussed with 
deterioration of social interaction with carers predicted. 
†Centre for Cognitive Aging & Epidemiology, Euan MacDonald Centre, University of Edinburgh, UK; s.abrahams@ed.ac.uk
  There is a clinical overlap between amyotrophic lateral sclerosis (ALS) and frontotemporal dementia 
(FTD), with 15% of ALS patients suffering from a full-blown FTD.
  A further third of ALS patients will have more subtle cognitive and behavioral change indicative of a 
‘subclinical FTD’ syndrome.
  Executive dysfunction is a predominant symptom, in particular with letter fluency deficits.
  Behavioral change is prevalent with increased apathy and self-centeredness commonly reported.
  Underlying cognitive deficits can be found on tests of social cognition, theory of mind, emotional 
processing and decision making.
  Some ALS patients may have particular problems in understanding another person’s perspective, or 
interpreting emotions and hence may appear egocentric and unresponsive in their viewpoint.
  It is predicted that some patients may experience a breakdown in social interaction and communication 
with carers.
  Clinicians should direct education strategies for those involved in the daily care of patients to shed light 
on this as an integral feature of the disease.
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Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS), the most 
common form of motor neuron disease, is a 
rapidly progressive and fatal condition, diag-
nosed on the basis of upper and lower motor 
neuron degeneration. The age of onset is typi-
cally 58–63 years and patients experience muscle 
wasting, weakness and spasticity, which is often 
focal at the beginning, affecting the limbs or 
bulbar region. The disease typically spreads 
to encompass other regions and death usually 
occurs within 30 months of onset of symptoms. 
The incidence is low at 2.16 per 100,000 and a 
familial link is found in 5% of patients (three 
major gene mutations having been identified), 
although the definition of familial ALS is con-
troversial [1,2]. Traditionally viewed as a dis-
ease exclusively of the motor system, there has 
been a substantial increase in reports of cogni-
tive change in ALS in recent years, and cogni-
tive deficits and behavior dysfunction are now 
viewed as an integral part of this multisystem 
disorder [3–6].
Amyotrophic lateral sclerosis 
to frontotemporal dementia: a 
clinicopathological spectrum
There is growing evidence of an overlap between 
ALS and frontotemporal dementia (FTD), the 
second most common dementia in those under 
65 years and a clinico-neuropathological spec-
trum has been proposed [7]. A small group of 
ALS patients suffer from a full blown demen-
tia syndrome (ALS-dementia), which is of a 
frontal type [8]. FTD consists of three distinct 
clinical syndromes; behavioral variant (bvFTD), 
progressive nonf luent aphasia and semantic 
dementia [9]. ALS-dementia most commonly 
resembles bvFTD. Language dysfunction in 
ALS has been described [10–12] with symptoms 
more often of the progressive nonfluent aphasia 
spectrum [13]. Reports of symptoms of seman-
tic dementia in ALS are rare [14,15]. Estimates 
of dementia prevalence within the ALS popu-
lation were at 3–5% [16]; however, these have 
risen to up to 15% when using more recent FTD 
diagnostic criteria, which are strongly based on 
behavior change [17–19]. This new estimation 
may also be conservative as patients with cog-
nitive impairment have a more rapid disease 
progression [18,20,21], and therefore studies that 
recruit from a prevalent rather than an incident 
population are likely to exhibit lower frequen-
cies of cognitive change. ALS may precede the 
dementia, develop concurrently or FTD may 
be the presenting complaint. ALS is present 
in up to 10% of FTD cases [8]. Distribution of 
pathology within ALS-dementia appears to be 
concentrated in the frontal lobes, (possibly even 
more prominently than in bvFTD in whom 
pathological spread also encompasses the tem-
poral lobes [22]). Support for a neuropathological 
continuum has been strengthened by reports of 
TDP-43 protein abnormalities in almost all ALS 
cases, the majority of ALS-FTD cases and up to 
half of FTD cases [23–25].
A clinical ALS-FTD spectrum has been 
further supported by the finding of executive 
dysfunction and corresponding prefrontal (pre-
dominantly dorsal) changes in a signifi cant pro-
portion of patients who do not have a full-blown 
dementia syndrome. These studies have consist-
ently found that approximately a third (38 [26], 
33 [27], 37 [19] and 36% [18]) of nondemented ALS 
patient samples show cognitive deficits on test-
ing. Deficits have been found on a range of tasks 
including those tapping rule deduction, cogni-
tive flexibility, attention, switching and moni-
toring (e.g., Wisconsin Card Sorting Test and 
Trail Making Tests) and letter and category flu-
ency [19,20,28–31]. Strong and colleagues have pro-
posed that these patients can be classified as ALS-
cognitive impairment, diagnosed on the basis of 
impairment on two distinct tests of executive 
functions [6]. Language changes have also been 
described with evidence of aphasia and naming 
impairment [20,26,29], while some reports have 
suggested that multiple domains are compro-
mised, including memory [18,32]. Deficits on letter 
fluency (rapid word generation beginning with a 
given letter) have been the most striking and con-
sistently reported in ALS [18,20,28–31,33,34]. Using a 
version of this task, which incorporates a writing/
motor condition and the production of a Verbal 
Fluency Index (average time to think of each 
word) this deficit was shown to be independent of 
physical disability [28,34]. Such slowed word gen-
eration has been shown in patients in the absence 
of language (naming) deficits, working memory 
problems of the phonological loop or store, and 
has been related to executive dysfunction of rapid 
intrinsic response generation [34]. This deficit is 
present early in the disease course [30], is more 
pronounced in ALS patients with pseudobulbar 
palsy [28], and in some familial forms of the dis-
ease (non-SOD1 but is absent in SOD1) [35] and 
in those with progressive muscular atrophy [36]. 
This deficit has also been shown to correlate with 
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eye-movement abnormalities (ocular fixation) a 
neurological marker [37]. Moreover, evidence of 
a prefrontal substrate to this cognitive profile has 
come from a range of brain imaging techniques 
further strengthening the view of an ALS-FTD 
spectrum [38]. Predominant dysfunction of the 
dorsolateral prefrontal cortex and anterior cin-
gulate gyrus has been revealed using functional 
brain imaging [29,33,39]; reduced neuronal receptor 
binding of Flumazenil has been shown in the 
inferior frontal gyrus [40] and frontotemporal 
white matter abnormalities were found through 
structural neuroimaging [41] while recent stud-
ies have in particular highlighted c allosal 
i nvolvement [42].
Although executive dysfunction is character-
istic of typical bvFTD (without ALS), diagnosis 
is based on behavior change and there has been 
considerable documentation of the predomi-
nant and early disruption in social and personal 
conduct [9,43]. Patients show emotional blunt-
ing, lack of insight, loss of empathy, selfishness, 
disinhibition and apathy [7,44], and such changes 
may be apparent prior to the development of 
deficits on traditional tests of executive func-
tions [21–23]. Despite this absence of overt execu-
tive dysfunction, impairments have been shown 
on more experimental tests of social cognition, 
emotional processing and emotional decision 
making [45–49]. Effective social interaction is 
dependent on the interpretation and exchange 
of specific social signals such as facial expression, 
body movement and direction of eye gaze [50] 
and changes to these processes may underlie 
the behavior changes evident in bvFTD [51]. 
Other abilities under the umbrella of ‘theory 
of mind’, involving inferring and representing 
others intentions and beliefs and attributing 
mental states to others that are independent 
from our own, have also been demonstrated to 
be affected in bvFTD [45,51,52]. Tasks tapping 
these functions may be sensitive to more medial 
and orbito frontal regions that are affected early 
in bvFTD [51,53,54]. In support of an ALS-FTD 
spectrum, parallel profiles of cognitive and 
behavior change should be present in ALS.
Social cognition in amyotrophic 
lateral sclerosis 
  Behavior change 
Within ALS, the primary profile of cognitive 
involvement has been one of executive dysfunc-
tion and corresponding changes in the more dor-
solateral and anterior medial prefrontal cortex. 
Evidence of behavior change and impairments 
in social and emotional cognition and involve-
ment of more orbital prefrontal pathways typi-
cal of bvFTD has only recently become a focus 
for investigation within the disorder [55]. In 
an influential paper, Lomen-Hoerth and col-
leagues highlighted that behavior change simi-
lar to that found in bvFTD was prevalent in 
ALS [27]. New-onset personality changes that 
met the criteria for FTD was found in all cases 
in which letter fluency deficits were present. 
Using the Neuropsychiatric Inventory, apathy, 
disinhibition and poor social monitoring were 
commonly reported. Moreover, a substantial 
number of patients with normal word generation 
also showed behavior change [27]. The estimated 
prevalence of behavior change in ALS may have 
been exaggerated somewhat in this study owing 
to the referral patterns to this particular clinic, 
but nevertheless the findings strengthened the 
view of a clinical overlap between ALS and 
FTD. Other studies have similarly reported 
behavior changes of apathy, irritability, aggres-
sion, stereotypy and disinhibition using the 
Neuropsychiatric Inventory [56,57]. Changes 
in apathy appear to be one of the most promi-
nent features within ALS. This is commonly 
reported using the Frontal Systems Behavior 
Scale (FrSBe) [58,59], which is designed to assess 
three domains (apathy, executive dysfunction 
and disinhibition). Moreover increased apathy in 
ALS using the FrSBe has been related to involve-
ment of the anterior cingulum as measured by 
diffusion tensor MRI [60]. A recent study of a 
large cohort of ALS patients (n = 225) revealed 
changes in at least one domain of the FrsBe in 
up to 39% of cases [61]. However, a difference 
appears to emerge between ALS and FTD cases 
in levels of insight with those ALS patients with 
mild behavior change showing insight with no 
significant difference between carer and self-rat-
ings of the FrSBe [62]. A criticism of such stud-
ies is the use of questionnaires developed and 
standardized for the head injury population, in 
whom physical disability is a less prominent fea-
ture. Several items on the FrSBe are confounded 
by motor disability, such as “is slow moving”, 
“lacks energy” and “is inactive”, which may 
exaggerate scores on the apathy scale. Measuring 
behavior change in ALS is further complicated 
by emotional reactions and coping with physical 
disability and terminal illness, and apathy may 
be a symptom of both an FTD-type behavior 
change and depression. However, studies that 
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have used more appropriate interview-based 
techniques have also revealed high levels of 
apathy within this population. A more detailed 
case-by-case carer interview was undertaken by 
Gibbons et al. [63]. Self-centeredness/selfishness 
was reported as the most prominent symptom 
in 11 of 16 patients and loss of interest/apa-
thy was found in six of 16. Other symptoms 
included aggression, loss of insight and social 
disinhibition described in two of 16 cases. A 
direct comparison of behavior dysfunction in 
ALS and bvFTD (without ALS) was undertaken 
by Lillo et al. using the Cambridge Behavior 
Inventory [64]. A total of 41% of ALS patients 
showed moderate-severe apathy. Depression was 
present in 30% of cases but regression analysis 
revealed that it did not significantly contribute 
to the presence of behavior symptoms [64]. As the 
majority of ALS patients do not meet the criteria 
for FTD, Strong and colleagues have proposed 
that ALS patients who show behavior change 
may be classified as ALS-behavioral impairment, 
diagnosed on the basis of two nonoverlapping 
supportive diagnostic features from either the 
Neary or Hodges’ criteria [6].
  Theory of mind
In parallel to the FTD literature deficits on 
theory of mind tests have now been reported 
in a significant proportion of ALS patients. 
Gibbons et al. investigated the interpretation of 
cartoons and stories that involved understand-
ing a character’s mental state (including false 
belief and deception) and revealed a spectrum 
of impairment ranging from normal to abnor-
mal scores in 16 ALS patients [65]. Deficits were 
more prominent in those with bulbar symptoms. 
However, ALS patients did not only have diffi-
culties with the ‘social’ components of this task 
but deficits were found in understanding physical 
scenarios in which humor was based on the phys-
ical properties of the scene. The same profile has 
been shown in FTD and, similarly, ALS patients 
also show an increase in concrete responses [46]. 
These tasks have a strong reasoning and infer-
ential component and hence executive dysfunc-
tion may have been a contributing factor if not 
at the root of this deficit. This was further sup-
ported by the finding that poor performance 
on the Wisconsin Card Sorting Task correlated 
with deficits on these tasks in the ALS group. 
More recently, Meier and colleagues employed 
the Faux Pas test to investigate theory of mind 
in ALS [66]. The test involves recognizing that a 
character in a particular scenario has said some-
thing that they should not have said. The test has 
been shown to be sensitive to FTD and to lesions 
to the ventromedial prefrontal cortex [45,67]. Nine 
of 18 ALS patients were impaired at identifying a 
faux pas when compared with controls. No dif-
ference was found between groups when using 
control stories that did not contain a faux pas ele-
ment [58]. By contrast to the Gibbons et al. study, 
some independence from executive dysfunction 
was revealed as the deficit remained relatively 
unchanged with covarying performance on l etter 
fluency [66].
A more selective ‘social’ deficit in ALS has 
been recently revealed by Cavallo et al. [68]. Here 
the understanding of social contexts was inves-
tigated using a cartoon-based story task that 
distinguished between inferring private (nonso-
cial) intentions versus social intentions. A private 
intention involves a goal that is only relevant to 
that one person, by contrast to a social inten-
tion that involves a social goal. Functional brain 
imaging has revealed greater prefrontal involve-
ment in the processing of social intentions as 
compared with the private intentions [69]. In 
keeping with this, ALS patients were signifi-
cantly worse at the ‘social’ items in contrast to 
controls who showed no significant difference 
between social and nonsocial items. A significant 
difference between these processes has also been 
reported in FTD patients [70]. 
In contrast to such complex social cognitive 
tasks that involve the understanding of detailed 
scenarios with multiple characters, behaviors, 
emotions and subtle nuances, Girardi et al. [60] 
reported deficits on a simple, undemanding the-
ory of mind test. The task previously shown to be 
sensitive to bvFTD [46] requires the participant 
to infer the preference of another by using eye-
gaze direction as a social cue. In the first phase of 
the Judgment of Preference task, the participant 
is asked to choose their own favorite of four pic-
tures. In phase two, a central face appears, which 
is looking and smiling at one of the objects, and 
the participant is required to select which pic-
ture ‘the face likes best’. Attentional demand 
was manipulated by the presence of a distracting 
arrow near one of the pictures. Although 64% of 
ALS patients were impaired on the attentionally 
demanding condition (with the distracter pres-
ent), which may have resulted from demands 
on executive functions, 36% were still impaired 
when the distracter was not present. An analysis 
of the errors showed that there was increased 
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selection of the patients’ own favorite object as 
opposed to that preferred by the face. Hence, on 
some trials, patients had difficulties in inhibit-
ing egocentric responding and in the use of a 
simple social cue (eye-gaze) to perform the task 
effectively. Of note, ALS patients had no dif-
ficulties in performing a third control phase in 
which the stimuli remained unchanged, but the 
wording was altered from ‘Which picture does 
the face like best?’ to ‘Which picture is the face 
looking at?’ Hence, the deficit did not appear 
to result from basic comprehension or primary 
attentional dysfunction. Deficits on this test 
were more prevalent than on traditional mea-
sures of executive functions in which only 29% 
of patients were impaired. Moreover, there was a 
link to increased behavioral dysfunction in this 
group with increased apathy related to poor 
performance on the task. By contrast, to the 
Gibbons et al. study, deficits were found in those 
with and without bulbar involvement, although 
there was a greater ratio of bulbar to limb patients 
in the cognitively impaired subset at a 2:1. This 
is supportive of previously described associations 
that suggest that those with bulbar involvement 
are more at risk of cognitive impairment [28].
  Emotion processing
Effective emotional processing is fundamental 
to theory of mind and social interaction. Deficits 
have been typically reported in bvFTD and simi-
lar dysfunction has now been described in ALS. 
Some studies have revealed that standard facial 
emotion recognition paradigms are sensitive to 
ALS [60,71], although this has not been consistently 
reported [72]. Deficits in identifying emotional 
prosody in speech have also been described [58] 
although Zimmerman et al. demon strated that 
this was not as sensitive as the face emotion rec-
ognition test [71]. Girardi and colleagues demon-
strated a deficit on two tests involving the under-
standing of both simple (Facial Expressions of 
Emotion test) and complex (Reading the Mind 
in the Eyes test) emotional expression. A sub-
group of patients performed poorly on both of 
these measures and the social cognition eye-gaze 
task reported previously. However, deficits on 
the more complex Reading the Mind in the Eyes 
test have not been consistently related to poor 
performance on other social cognition measures 
in ALS [68]. Further studies have demonstrated 
that this emotional processing deficit is selective 
and is not a manifestation of general cognitive 
decline or attentional dysfunction. Papps et al. 
demonstrated that ALS patients failed to show 
enhanced recognition of emotional words, a phe-
nomena that is apparent in controls. This deficit 
could not have resulted from general memory 
dysfunction as ALS patients’ performance on 
recognizing neutral words was superior to that 
of controls [72]. 
In terms of the social relevance of emotion 
perception, Schmlok et al. revealed that ALS 
patients rated faces as more approachable than 
controls [73], while Lule and colleagues revealed 
that ALS patients tended to show a more posi-
tive valence towards emotive social situations 
and rated calm pictures as more exciting and 
vice versa, resulting in a more balanced state of 
arousal than controls [74]. Levels of arousal were 
subsequently related to patterns of increased 
and decreased activation using fMRI (increased 
activation was observed in the supramarginal 
gyrus and reduced activation in the extrastriate 
visual areas in ALS patients). Moreover, changes 
occurred in the anterior insula over time, which 
correlated with subjective reports of arousal. 
Further evidence of the cerebral substrate of the 
emotional processing dysfunction in ALS comes 
from a recent fMRI study in which during an 
emotional decision task, participants were asked 
to select the most unpleasant (or neutral) word 
from a series of three words and subsequent rec-
ognition of this emotional material [75]. Both 
decision and recognition tasks were associated 
with reduced activation in the right hemisphere 
in ALS patients and an increase in the left hemi-
sphere in comparison with controls. This later-
alized dysfunction appears consistent with the 
findings of Murphy et al. who found that ALS 
patient with FTD and more subtle behavioral 
disturbance had significantly more gray matter 
volume reductions in the right hemisphere (as 
revealed through structural MRI) in comparison 
with ALS patients without cognitive or behav-
ioral abnormalities. The authors proposed that 
right hemisphere atrophy was a biomarker for 
behavioral abnormalities in ALS [76]. 
Of note, up to half of ALS patients show a 
dysregulation of emotional expression termed 
emotional lability. The relationship of this 
loss of emotional control to the defi cit in emo-
tional processing has not yet been investigated, 
although recent studies have demonstrated that 
lability does not appear to be directly related to 
other cognitive deficits present in ALS and sug-
gests differing neuronal pathways underlying 
these symptoms [77]. 
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  Decision making 
There is now growing evidence to suggest that 
the cognitive impairment in ALS encompasses 
decision-making processes including those reli-
ant on more orbitomedial prefrontal functions. 
A typical paradigm involves reward learning 
and deficits have been revealed in a modified 
version of the Iowa gambling task [60], which 
has been shown to be sensitive to ventromedial 
lesions [78] and FTD [79], although no defi-
cits were reported on a probabilistic reversal 
learning task [58] also sensitive to ventromedial 
lesions. Using a version of the Iowa gambling 
task, Girardi and colleagues revealed that 
ALS patients made no adjustment to their 
performance in response to the negative con-
sequences of losing money and continued to 
select from high-risk decks in comparison with 
controls [60]. Poor performance was also related 
to overall behavioral change as measured by 
the FrSBe. However, it should be noted that 
performance of ALS patients did not resemble 
that of FTD in whom there appears to be an 
increased selection from high-risk decks as the 
task continues [79]. By contrast, ALS patients’ 
performance remained stable throughout the 
test, indicating a failure to learn that may have 
resulted from more executive dysfunction. This 
is consistent with the finding that poor per-
formance may also be affected by dorsolateral 
prefrontal dysfunction [80]. Further evidence 
of affected decision-making processes in ALS 
comes from a recent study that employed an 
attribute-based decision-making task [66]. In 
the Holiday Apartment task, the participant 
must select a suitable apartment on the basis 
of assessment of multiple attributes. It has 
previously been demonstrated that patients 
with ventromedial lesions use different search 
strategies (apartment by apartment) than those 
of dorsolateral prefrontal damage who use an 
attribute-based strategy. A total of 44% of ALS 
patients showed a more apartment based search 
strategy on more complex trials, similar to that 
of patients with ventromedial lesions. This is of 
particular interest as the affective and risk com-
ponent of decision making has been removed 
and hence has clear implications for decision 
making within everyday life. 
Conclusion & future perspective
A subgroup of ALS patients appear to show dys-
function in social cognition and corresponding 
behavior change that is parallel to that found in 
bvFTD. Dysfunction ranges in severity from a 
full-blown dementia syndrome characterized by 
marked behavior change to a more from subtle 
impairment. The latter reflects a profile of ‘sub-
clinical’ FTD in a significant proportion of 
cases and provides further support for a clinico-
pathological spectrum. Several unresolved issues 
remain – most prominently, to what extent these 
changes can be related or explained by execu-
tive dysfunction, which is clearly present in the 
disease. Executive dysfunction and more dorsal 
prefrontal involvement are known to produce 
impairments on some of these experimental cog-
nitive tasks. Moreover, there is still an absence of 
direct evidence of changes to the orbitomedial 
cortex as found in early changes in bvFTD. If 
executive dysfunction and social cognitive defi-
cit emerge as independent features, the question 
arises of whether these deficits are reflective of 
different subphenotypes with separable distri-
bution of prefrontal pathology. Longitudinal 
studies in ALS are notoriously difficult to per-
form owing to progressive disability and high 
attrition rates; however, these are necessary 
to determine the course of these changes and 
shed further light on heterogeneity of impair-
ment. Poor prognosis has been associated with 
cognitive change in ALS [18,20,21]. If this is also 
true of those with a social cognition deficit, 
the question arises of whether this is a primary 
consequence of disease progression with those 
with associated cognitive symptom experienc-
ing a more aggressive disease, whether this is a 
secondary consequence of different treatment 
strategies being offered to those with cognitive 
dysfunction, or whether this is a factor of those 
cognitively impaired ALS patients not adhering 
to treatment. 
The impact of such changes on daily life is 
yet to be investigated and has clear implica-
tions for the daily management of ALS patients. 
Potential problems may emerge in using social 
cues to guide behavior in interpreting the emo-
tions and the intentions of others resulting in 
problems with social interaction. Some ALS 
patients may fail to see another person’s per-
spective and appear self-centered with a loss of 
concern for their partner’s/families’ feelings, 
resulting in deteriorating social relationships 
with carers. An ALS patient during the course 
of their illness becomes increasingly dependent 
on those in their immediate environment and 
hence a breakdown in effective social interac-
tion is likely to have considerable impact on 
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the everyday life of the family. Further prob-
lems may emerge in decision making in fully 
understanding the consequences of their own 
actions. This has particular relevance for deci-
sion making over disease-specific issues such as 
treatment and end-of-life care, in addition to 
secondary issues such as organizing finances and 
planning for the future of the family. Where 
dysfunction in social cognition is suspected, cli-
nicians should use education strategies to inform 
those involved in the direct care of the patient 
(including healthcare professionals and family 
and friends) of the range of potential symptoms 
(e.g., inability to see another’s perspective and 
apathy) and the impact that these changes may 
have on relationships and social interactions 
with those around them. Most importantly, 
carers should be educated that these symptoms 
are an integral part of the disease and often not 
a symptom of other secondary factors associated 
with their relationship. 
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